C.I. MedicalLtd Resultados de beneficios anteriores

Pasado controles de criterios 5/6

C.I. MedicalLtd ha aumentado sus beneficios a una tasa media anual de 6.4%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 6.4% anual. Los ingresos han ido creciendo a una tasa media de 10.4% al año. La rentabilidad financiera de C.I. MedicalLtd es de 22.7%, y sus márgenes netos son de 9.9%.

Información clave

6.4%

Tasa de crecimiento de los beneficios

6.4%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	7.9%
Tasa de crecimiento de los ingresos	10.4%
Rentabilidad financiera	22.7%
Margen neto	9.9%
Última actualización de beneficios	30 Sep 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

Feb 18

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Jan 31

Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?

Jan 13

Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?

Dec 26

Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?

Dec 08

Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?

Nov 20

Desglose de ingresos y gastos

Cómo gana y gasta dinero C.I. MedicalLtd. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

TSE:3540 Ingresos, gastos y beneficios (JPY Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Sep 24	57,228	5,680	14,852
30 Jun 24	47,747	1,433	10,081
31 Mar 24	46,575	1,808	9,562
31 Dec 23	45,628	2,082	9,004
30 Sep 23	45,071	2,162	8,452
30 Jun 23	44,125	2,219	8,132
31 Mar 23	43,473	2,173	7,931
31 Dec 22	42,891	2,521	7,681
30 Sep 22	42,073	2,709	7,533
30 Jun 22	41,754	2,798	7,358
31 Mar 22	41,142	2,815	7,242
31 Dec 21	41,205	2,820	7,081
30 Sep 21	41,500	3,182	7,041
30 Jun 21	40,833	3,334	6,872
31 Mar 21	39,593	3,309	6,622
31 Dec 20	37,393	2,920	6,590
30 Sep 20	33,251	2,263	6,260
30 Jun 20	31,964	1,924	6,093
31 Mar 20	30,265	1,608	5,959
31 Dec 19	28,763	1,505	5,653
30 Sep 19	28,876	1,571	5,475
30 Jun 19	26,898	1,345	5,268
31 Mar 19	26,484	1,414	5,112
31 Dec 18	25,806	1,329	4,945
30 Sep 18	24,892	1,358	4,757
30 Jun 18	24,323	1,458	4,523
31 Mar 18	23,336	1,445	4,263
31 Dec 17	22,830	1,539	4,088
30 Sep 17	21,999	1,486	3,932
30 Jun 17	21,440	1,497	3,881
31 Mar 17	20,887	1,390	3,794
31 Dec 16	20,334	1,282	3,706
31 Dec 15	18,145	1,088	3,079
31 Dec 14	16,084	901	2,712

Ingresos de calidad: 3540 tiene una única gran ganancia de ¥4.6B que afecta a sus resultados financieros de los últimos 12 meses de 30th September, 2024.

Margen de beneficios creciente: Los actuales márgenes de beneficio (9.9%) de 3540 son superiores a los del año pasado (4.8%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de 3540 han crecido un 6.4% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de 3540 en el último año (162.7%) supera su media de 5 años (6.4% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de 3540 en el último año (162.7%) superó al de la industria Healthcare 10.6%.

C.I. MedicalLtd Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Información clave

Actualizaciones de resultados anteriores recientes

Third quarter 2024 earnings released: EPS: JP¥95.20 (vs JP¥10.26 in 3Q 2023)

Second quarter 2024 earnings released

C.I. Medical Co.,Ltd. to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: EPS: JP¥24.70 (vs JP¥52.11 in 1Q 2023)

Full year 2023 earnings released: EPS: JP¥208 (vs JP¥252 in FY 2022)

C.I. Medical Co.,Ltd. to Report Fiscal Year 2023 Results on Feb 13, 2024

Recent updates

New major risk - Revenue and earnings growth

Third quarter 2024 earnings released: EPS: JP¥95.20 (vs JP¥10.26 in 3Q 2023)

C.I. MedicalLtd (TSE:3540) Has A Somewhat Strained Balance Sheet

New minor risk - Profit margin trend

Second quarter 2024 earnings released

C.I. Medical Co.,Ltd. (TSE:3540) Looks Just Right With A 25% Price Jump

Investor sentiment improves as stock rises 36%

New minor risk - Share price stability

New minor risk - Dividend sustainability

Investor sentiment improves as stock rises 20%

C.I. Medical Co.,Ltd. to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: EPS: JP¥24.70 (vs JP¥52.11 in 1Q 2023)

C.I. Medical Co.,Ltd. (TSE:3540) signed sale and purchase agreement to acquire Nissen Holdings Co., Ltd. from Seven & i Net Media Co., Ltd. for ¥4.1 billion.

C.I. Medical Co.,Ltd. (TSE:3540) signed sale and purchase agreement to acquire Nissen Holdings Co., Ltd. from Seven & i Net Media Co., Ltd. for ¥4.1 billion.

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 26, 2024

Full year 2023 earnings released: EPS: JP¥208 (vs JP¥252 in FY 2022)

C.I. Medical Co.,Ltd. to Report Fiscal Year 2023 Results on Feb 13, 2024

Upcoming dividend of JP¥25.00 per share at 0.6% yield

Investor sentiment improves as stock rises 15%

New major risk - Financial position

Third quarter 2023 earnings released: EPS: JP¥51.29 (vs JP¥57.01 in 3Q 2022)

C.I. Medical Co.,Ltd. to Report Q3, 2023 Results on Nov 14, 2023

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: JP¥70.50 (vs JP¥65.91 in 2Q 2022)

C.I. Medical Co.,Ltd. to Report Q2, 2023 Results on Aug 08, 2023

First quarter 2023 earnings released: EPS: JP¥52.10 (vs JP¥86.91 in 1Q 2022)

Full year 2022 earnings: EPS misses analyst expectations

Now 23% undervalued after recent price drop

Consensus EPS estimates fall by 16%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

C.I. Medical Co.,Ltd. to Report Fiscal Year 2022 Results on Feb 14, 2023

Upcoming dividend of JP¥28.50 per share

Third quarter 2022 earnings released: EPS: JP¥57.01 (vs JP¥65.91 in 3Q 2021)

Third quarter 2022 earnings released: EPS: JP¥56.99 (vs JP¥65.91 in 3Q 2021)

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Naiki Shiken Ltd. from Yuichi Naiki and Yuriko Naiki.

C.I. Medical Co.,Ltd. to Report Q3, 2022 Results on Nov 08, 2022

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Sakura Dental Laboratory from Akira Ochi and Katsumi Ochi.

Second quarter 2022 earnings released: EPS: JP¥65.90 (vs JP¥67.61 in 2Q 2021)

C.I. Medical Co.,Ltd. to Report Q2, 2022 Results on Aug 09, 2022

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to JP¥4,300

C.I. Medical Co.,Ltd. to Report Q1, 2022 Results on May 10, 2022

Investor sentiment improved over the past week

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 24, 2022

Full year 2021 earnings: EPS misses analyst expectations

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased to JP¥5,300

Third quarter 2021 earnings released: EPS JP¥65.89 (vs JP¥81.10 in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥67.61 (vs JP¥65.10 in 2Q 2020)

Investor sentiment deteriorated over the past week

Looop Inc. agreed to acquire 60% stake in Niigata Prefectural Electric Power Co., Ltd. and Yotsuba Electric Power Co., Ltd. from C.I. Medical Co.,Ltd. (JASDAQ:3540).

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥87.40 (vs JP¥48.50 in 1Q 2020)

Here's Why We Think C.I. MedicalLtd (TYO:3540) Is Well Worth Watching

Returns on Capital Paint A Bright Future For C.I. MedicalLtd (TYO:3540)

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Investor sentiment improved over the past week

Should You Investigate C.I. Medical Co.,Ltd. (TYO:3540) At JP¥5,450?

New 90-day low: JP¥5,490

Analysts increase EPS estimates to JP¥320

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

C.I. Medical Co.,Ltd. (JASDAQ:3540) acquired 22.4% stake in Fuji Dental Lab Co., Ltd.

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Revenue and earnings beat expectations

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Yosuke Oda Kaki and Keisuke Hori agreed to acquire an additional 60% stake in One Recto Holdings Co., Ltd. from C.I. Medical Co.,Ltd. (JASDAQ:3540).

New 90-day low: JP¥5,900

Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?